News Detail
Mumbai, 26 Aug 2024: The Centre’s ongoing efforts to remove ‘irrational’ combination drugs from the market has reignited the discussion on science versus commerce.
While some companies are seeking time to recall existing inventory, others like Emcure ......
View Details
Source : The Hindu
FDC
fixed-dose combination
science versus commerce
Emcure
Health Ministry
Harish K Jain
Dr Sanjit Singh Lamba
former head of Eisai
India
therapeutic -- analgesics and psychotropics
lack of rigorous regulatory oversight and sub-optimal enforcement
safety and efficacy
S Srinivasan
Locost
the All India Drug Action Network
Related News
- Cipla gets nod to market Afrezza insulin inhalation powder in India (12-12-2024)
- UK regulator probes anti-depressants safety alerts after suicide link (12-12-2024)
- Haryana Food Department to Crack Down on Fake Protein Supplements After Major Bust (12-12-2024)
- Drug inspector sentenced to 3-yr rigorous imprisonment (12-12-2024)
- 11.12 crore worth of short-shelf life medicines expired due to delayed supply to TNMSC: CAG Report (12-12-2024)
- Ayush Ministry amends D&C Act to add Homoeopathy, Sowa Rigpa books and Pharmacopoeias (12-12-2024)
- Construction of all three bulk drug parks are in progress: Ministry of chemicals (12-12-2024)
- Four-member gang nabbed for selling ‘Mephentermine Sulphate’ injections in Hyderabad (12-12-2024)
- Combining BCL-2 and BTK inhibitors shows promise in chronic lymphocytic leukemia (CLL) (11-12-2024)
- Punjab cop arrests man for narcotic drugs case, gets fined by court (11-12-2024)